Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
|Videos|July 13, 2015
Dr. Andrew M. Kaunitz Provides an Overview of Bioidentical Hormone Therapy
Author(s)Andrew M. Kaunitz, MD, FACOG
Andrew M. Kaunitz, MD, FACOG, professor, Associate Chair, Department of Obstetrics and Gynecology, University of Florida College of Medicine - Jacksonville, provides an overview of bioidentical hormone therapy.
Advertisement
Andrew M. Kaunitz, MD, FACOG, professor, Associate Chair, Department of Obstetrics and Gynecology, University of Florida College of Medicine — Jacksonville, provides an overview of bioidentical hormone therapy.
Advertisement
Related to this article
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Male Breast Cancer: Managing Endocrine Therapy and Survivorship Care
2
AI Breast Cancer Risk Models Guide Triage and Nurse-Led Patient Counseling
3
Nurses Can Catch Breast Cancer Lymphedema Early With Baseline BIS
4
Fear of Cancer Recurrence Care: What Clinicians Say Is Feasible
5